Ph-Responsive Hyaluronic Acid Nanoparticles Codelivering DOX and ICG for Effectively Chemo-Photothermal Combination Therapy

Chen Gang,Wei Pei,Huang Long,Lei Mengheng,Zhang Mengyao,Lei Jiaqing,Zheng Hua,Li Dan
DOI: https://doi.org/10.1007/s11051-021-05343-w
IF: 2.533
2021-01-01
Journal of Nanoparticle Research
Abstract:Insufficient cumulative release of chemotherapeutics at the tumor site and poor efficacy of monotherapy are the main reasons for the unsatisfactory effect of cancer therapy at present. Here, a pH-responsive nanoparticle (DAH@ICG NP) based on hyaluronic acid (HA) was designed which was loaded with the photosensitizer indocyanine green (ICG) and chemotherapeutic doxorubicin (DOX) for chemo-photothermal combination therapy against cancer. Besides, the in vitro stability, acid-sensitive release behavior, photothermal efficiency, in vitro cytotoxicity, and cell selectivity index of the DAH@ICG NPs were evaluated. Accordingly, the DAH@ICG NPs had a hydrodynamic particle size of 150.3 nm. The drug loading of DOX and ICG in the DAH@ICG 5-1 NPs was 21.2% and 10.40%, respectively. What’s more, compared with human umbilical vein endothelial cells (HUVECs), in vitro cytotoxicity assay against 4T1 cells showed that the nano-delivery system showed higher cell-killing performance and the cell selectivity index (selectivity index = 9.52). More importantly, the cellular uptake of the laser-irradiated group was significantly enhanced owing to the heat generated by the photosensitizer ICG, which can improve cell membrane fluidity and destroy the extracellular matrix. Taken together, DAH@ICG NPs may be promising nanoplatforms to achieve a synergistic therapeutic effect for the combination of chemotherapy and photothermal therapy (PTT).
What problem does this paper attempt to address?